Dynamic contrast-enhanced imaging techniques: CT and MRI

British Journal of Radiology

Volumn 84, Issue SPEC. ISSUE 2, 2011, Pages

  O'Connor, J P B ^a   Tofts, P S ^b   Miles, K A ^b   Parkes, L M ^a   Thompson, G ^a   Jackson, A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN BLOOD VESSEL; BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; IMAGE ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY; BRAIN; IMAGE ENHANCEMENT; IMAGE PROCESSING; METHODOLOGY; PATHOLOGY; RADIOGRAPHY; REVIEW; SPIN LABELING;

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; SPIN LABELS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84867218251     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/55166688     Document Type: Article

References (44)

1. Jackson A, Buckley DL, Parker GJM. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology 2005, Berlin, Germany: Springer.
2. Miles KA, Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 2003;76:S36-42. (Pubitemid 39530314)
3. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement? Br J Radiol 2003;76:220-31. (Pubitemid 36582066)
4. Xie Q, Zhang J, Wu PH, Jiang XQ, Chen SL, Wang QL, et al. Bladder transitional cell carcinoma:correlation of contrast enhancement on computed tomography with histological grade and tumour angiogenesis. Clin Radiol 2005;60:215-23. (Pubitemid 40123495)
5. Wang JH, Min PQ, Wang PJ, Cheng WX, Zhang XH, Wang Y. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol 2006;186:1423-30. (Pubitemid 46112581)
6. Tateishi U, Kusumoto M, Nishhihara H, Nagashima K, Morikawa T, Moriyama N. Contrast-enhanced dynamic computed tomography for the evaluation of tumor angio-genesis in patients with lung carcinoma. Cancer 2002; 95:835-42. (Pubitemid 34839676)
7. Miles KA, Young H, Chica SL, Esser PD. Quantitative contrast-enhanced computed tomography:is there a need for system calibration? Eur Radiol 2007;17:919-26. (Pubitemid 46766873)
8. Gillard JH, Antoun NM, Burnet NG, Pickard JD. Reproducibility of quantitative CT perfusion imaging. Br J Radiol 2001;74:552-5. (Pubitemid 32674216)
9. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 2000;21:462-70. (Pubitemid 30149336)
10. Lee T-Y, Miles KA. Image processing. In: Miles KA, Cuenod C-A, editors. Multi-detector computed tomography in oncol-ogy: CT perfusion imaging. London, UK: Informa, 2007:61-72.
11. Youn SW,Kim JH, Wean YC, Kim SH, Han MK, Bae HJ. Perfusion CT of the brain using 40-mm-wide detector and toggling table technique for initial imaging of acute stroke. AJR Am J Roentgenol 2008;191:W120-6.
12. O'Connor JPB, Jackson A, Asselin MC, Buckley DL, Parker GJM, Jayson GC. Quantitative imaging biomarkers in the clinical development of targeted therapeutics current and future perspectives. Lancet Oncol 2008;9:756-66.
13. Miles KA. Perfusion CT-PET: opportunities for combined assessment of tumor vascularity and metabolism. In: Miles KA, editor. Multi-detector computed tomography in oncol-ogy: CT perfusion imaging. London, UK: Informa, 2007.
14. Calamante F, Thomas DL, Pell GS, Wiersma J, Turner R. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab 1999;19:701-35. (Pubitemid 30159797)
15. Li KL, Zhu XP, Jackson A. Parametric mapping of scaled fitting error in dynamic susceptibility contrast enhanced MR perfusion imaging. Br J Radiol 2000;73:470-81. (Pubitemid 30311487)
16. van Gelderen P, Grandin C, Petrella JR, Moonen CTW. Rapid three-dimensional MR imaging method for tracking a bolus of contrast agent through the brain. Radiology 2000;216:603-8. (Pubitemid 30599889)
17. Jackson A, O'Connor J, Thompson G, Mills S. Magnetic resonance perfusion imaging in neuro-oncology. Cancer Imaging 2008;8:186-99.
18. Batchelor TT, Duda DG, di Tomaso E, Ancukiewicz M, Plotkin SR, Gerstner E, et al. Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyr-osine kinase inhibitor, in patients with recurrent glioblas-toma. J Clin Oncol 2010;28:2817-23.
19. Jackson A, Kassner A, Annesiey-Williams D, Reid H, Zhu XP, Li KL. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas:compar-ison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 2002;23:7-14. (Pubitemid 34098254)
20. 2O positron emission tomogra-phy in humans. J Cereb Blood Flow Metab 1998;18:935-40.
21. Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006;56:993-1000. (Pubitemid 44691341)
22. Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging:issues and recommendations. Br J Cancer 2005;92:1599-610. (Pubitemid 40756468)
23. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254-9. (Pubitemid 29463107)
24. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 1998; 18:1365-77. (Pubitemid 28559684)
25. Jackson A, O'Connor JP, Parker GJ, Jayson GC. Imaging tumor vascular heterogeneity and angiogenesis using DCE-MRI. Clin Cancer Res 2007;13:3449-59.
26. Buckley DL, Kerslake RM, Blackband SJ, Horsman A. Quantitative analysis of multi-slice Gd-DTPA enhanced dynamic MR images using an automated simplex minimiza-tion procedure. Magn Reson Med 1994;32:646-51. (Pubitemid 24338213)
27. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101. (Pubitemid 28365643)
28. Tofts PS. Measurement of the blood-brain barrier perme-ability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17: 357-67.
29. Barrett T, Brechbiel M, Bernardo M, Choyke PL. MRI of tumor angiogenesis. J Magn Reson Imaging 2007;26:235-49. (Pubitemid 47257720)
30. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffu-sable tracer:standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32. (Pubitemid 29463104)
31. Law M, Kazmi K, Wetzel S, Wang E, Lacab C, Zagzag D, et al. Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors. AJNR Am J Neuroradiol 2004;25:997-1005. (Pubitemid 38765880)
32. Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711-16. (Pubitemid 34178155)
33. O'Connor JP, Jackson A, Parker GJM, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007;96:189-95. (Pubitemid 46160619)
34. O'Connor JPB, Carano RAD, Clamp AR, Ross J, Ho CCK, Jackson A, et al. Quantifying antivascular effects of mono-clonal antibodies to vascular endothelial growth factor: insights from imaging. Clin Cancer Res 2009;15:6674-82.
35. Galbraith SM, Lodge MA, Taylor NJ, Rustin GJ, Bentzen S, Stirling JJ, et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 2002;15:132-42. (Pubitemid 34213403)
36. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;23:37-45.
37. Kim HS, Kim SY, Kim JM. Underestimation of cerebral perfusion on flow-sensitive alternating inversion recovery image: semiquantitative evaluation with time-to-peak values. AJNR Am J Neuroradiol 2007;28:2008-13. (Pubitemid 350174753)
38. Luh WM, Wong EC, Bandettini PA, Hyde JS. QUIPSS II with thin-slice TI1 periodic saturation:a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med 1999;41:1246-54. (Pubitemid 29247294)
39. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996;16:1236-49. (Pubitemid 26365376)
40. Parkes LM, Tofts PS. Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling: accounting for capillary water permeability. Magn Reson Med 2002;48:27-41. (Pubitemid 34721585)
41. Parkes LM. Quantification of cerebral perfusion using arterial spin labeling: two-compartment models. J Magn Reson Imaging 2005;22:732-6. (Pubitemid 41741239)
42. Petersen ET, Mouridsen K, Golay X. The QUASAR reprodu-cibility study, Part II:Results from a multi-center Arterial Spin Labeling test-retest study. Neuroimage 2010;49:104-13.
43. Brown GG, Clark C, Liu TT. Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications. J Int Neuropsychol Soc 2007;13:526-38. (Pubitemid 47307493)
44. Buxton RB, Uludaǧ K, Dubowitz DJ, Liu TT. Modeling the hemodynamic response to brain activation. Neuroimage 2004;23:S220-33. (Pubitemid 39421721)